Cargando…

Progress in hepatectomy for hepatocellular carcinoma and peri-operation management

The global incidence of liver cancer continues to grow. Liver cancer, especially hepatocellular carcinoma, has high recurrence and mortality rates. Here, we review the past decade's diagnostic, therapeutic, and management strategies for hepatocellular carcinoma, and summarize new patient manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hao, Jia, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452507/
https://www.ncbi.nlm.nih.gov/pubmed/32884986
http://dx.doi.org/10.1016/j.gendis.2020.02.001
_version_ 1783575175441154048
author Chen, Hao
Jia, Weidong
author_facet Chen, Hao
Jia, Weidong
author_sort Chen, Hao
collection PubMed
description The global incidence of liver cancer continues to grow. Liver cancer, especially hepatocellular carcinoma, has high recurrence and mortality rates. Here, we review the past decade's diagnostic, therapeutic, and management strategies for hepatocellular carcinoma, and summarize new patient management approaches, including enhanced recovery after surgery, targeted therapy, and immunotherapy. We compare traditional and innovative management methods, which comprise developments in precision medicine, and consider their limitations. Ongoing innovation and technological advances enable surgeons to gain deeper understandings of the multidimensionality of hepatocellular carcinoma, thereby promoting the continuous development of precision therapy.
format Online
Article
Text
id pubmed-7452507
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Chongqing Medical University
record_format MEDLINE/PubMed
spelling pubmed-74525072020-09-02 Progress in hepatectomy for hepatocellular carcinoma and peri-operation management Chen, Hao Jia, Weidong Genes Dis Article The global incidence of liver cancer continues to grow. Liver cancer, especially hepatocellular carcinoma, has high recurrence and mortality rates. Here, we review the past decade's diagnostic, therapeutic, and management strategies for hepatocellular carcinoma, and summarize new patient management approaches, including enhanced recovery after surgery, targeted therapy, and immunotherapy. We compare traditional and innovative management methods, which comprise developments in precision medicine, and consider their limitations. Ongoing innovation and technological advances enable surgeons to gain deeper understandings of the multidimensionality of hepatocellular carcinoma, thereby promoting the continuous development of precision therapy. Chongqing Medical University 2020-03-28 /pmc/articles/PMC7452507/ /pubmed/32884986 http://dx.doi.org/10.1016/j.gendis.2020.02.001 Text en © 2020 Chongqing Medical University. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Chen, Hao
Jia, Weidong
Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
title Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
title_full Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
title_fullStr Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
title_full_unstemmed Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
title_short Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
title_sort progress in hepatectomy for hepatocellular carcinoma and peri-operation management
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452507/
https://www.ncbi.nlm.nih.gov/pubmed/32884986
http://dx.doi.org/10.1016/j.gendis.2020.02.001
work_keys_str_mv AT chenhao progressinhepatectomyforhepatocellularcarcinomaandperioperationmanagement
AT jiaweidong progressinhepatectomyforhepatocellularcarcinomaandperioperationmanagement